Advertisement

Picture Berlin Partner Top News Aignostics Mayo Clinic Pathology 650x100px

Persons > All

Find below all kinds of persons.

Total search results: 9470 | Ordered by Person (ascending)
next pagenext page 1 2 3 ... 93 94 95  next pagenext page

order ascendingorder descendingPerson order ascendingorder descendingPosition order ascendingorder descendingOrganisation (Group) order ascendingorder descendingCountry
Wood, Clive R. (Boehringer 201403– SVP Discovery Research before Bayer HealthCare + Dyax) President/Director/Head Business Group/Unit/Division Boehringer Ingelheim (Group) Germany
Wood, Fleur (BenevolentAI 202309 VP Investor Relations) Public Relations Manager / Investor Relations Manager BenevolentAI (Group) United Kingdom (GB)
Woodford, Neil (Woodford Investment) Investment Manager Woodford Investment (Group) United Kingdom (GB)
Woodrow, Gordon (Proteros Biostructures 201008 EVP Strategic Alliances) Business Development Manager / Strategy Manager Proteros (Group) United Kingdom (GB)
Woods, Kate (Northbank 200411) n. a. Instinctif Partners (Group) Germany
Woods, R. Keith (Argen-X 201804– COO before Alexion + Roche + Amgen + Eisai) Chief Operating Officer (COO) Argenx (Argen-X) (Group) Netherlands
Woods, Steve (Inovia Capital 202408 Partner) Partner (venture partner) Inovia Capital Inc. (CA) Canada
Woolfenden, Elizabeth (Liz) (Markes 200902 Director) President/Director/Head Business Group/Unit/Division Schauenburg (Group) United Kingdom (GB)
Woolford, John (Westwicke Partners 201807) Public Relations Manager / Investor Relations Manager ICR (Group) United States (USA)
Woolfson, Adrian (Replay 202208 Executive Chair + Co-Founder before Sangamo + Nouscom + Pfizer + BMS) Board member, executive Replay (Group) United States (USA)
Worland, Steve (Effector Therapeutics 201512 CEO before Anadys + Pfizer) Chief Executive Officer (CEO) Effector Therapeutics Inc. United States (USA)
Worrall, Matthew (Matt) (Ferring 202410 Director Corporate Communications + Public Affairs) Public Relations Manager / Investor Relations Manager Ferring (Paulsen Foundation) (Group) Switzerland
Worseck, Josephine (Metabolomic Discoveries 201501 Head of Business Development) Business Development Manager / Strategy Manager Metabolon (Group) Germany
Wortelmann, Thomas (GAS GmbH 201311 Managing Director) Managing Director Imspex (Group) Germany
Wowk, Steve (Danaher 202405 VP/General Manager of Gene reading Business Unit at IDT) General Manager (management) Danaher (Group) United States (USA)
Wozniewski, Thomas (Takeda 201611 Global Manufacturing + Supply Officer) Production Manager Takeda (Group) Japan
Wright, Edward (Bayer 201611 Bayer Yakuhin) n. a. Bayer (Group) Japan
Wright, Teresa (Roche Molecular 200809 CMO) Chief Medical Officer (CMO) Roche (Group) United States (USA)
Wright, Timothy M. (TIME BioVentures 202012 General Partner before Regulus Therapeutic + CIBR + Novartis + Pfizer) General Partner (venture partner) TIME BioVentures
Wrobel, Walter-G. (Retina Implant 201603 CEO) Chief Executive Officer (CEO) Retina Implant AG Germany
Wu, Ching (Excellims 202107 CEO + Founder) Chief Executive Officer (CEO) Excellims Corporation United States (USA)
Wu, Julie (Full-Life Technologies 202401 CFO) Chief Financial Officer (CFO) Full-Life Technologies (Group) China
Wu, Xiaodong (China Medical Technologies 201108 CEO) Chief Executive Officer (CEO) China Medical Technologies (Group) China
Wu, Xu (Creat 201704 CEO) Chief Executive Officer (CEO) Creat (Group) China
Wulf, Karsten (Wulf Group 202111 Managing Partner + Owner + Founder before buw Group) Managing Partner WULF Group (family of Karsten Wulf / zwei.7) Germany
Wulf, Sylke (Thermo Fisher 201006 Thermo Fisher Deutschland Regional Head Chromatography North) Regional manager Thermo Fisher (Group) Germany
Wulf-Fuhrmann, Gabriele (Niedersachsen (govt) 201410– Vice President of LAVES) Administrative Officer (personnel) Niedersachsen (govt region) Germany
Wulfetange, Camilla (Scienion 201206) n. a. Bico (Group) Germany
Wunderlin, Markus (Univ Ulm 20107 Service Center Mass Spectrometry) Head Mass Spectrometry / NMR Laboratory (university / research institute) University of Ulm Germany
Wupperfeld, Udo (Leonardo Venture 2007) n. a. Leonardo Venture GmbH & Co. KGaA Germany
Wurm, Florian (ExcellGene 200905 CSO + founder) Chief Scientific Officer (CSO) / Chief Development Officer (CDO) ExcellGene S.A. Switzerland
Wurm, Thomas (Single Use Support 201911 Managing Director + Co-Founder) n. a. Novo Group (Group) Austria
Wurst, Helmut (Cellendes GmbH 200907– Managing Director + Founder) Managing Director Cellendes GmbH Germany
Wuurman, Bart (Apaxen 202011– CEO before Lyramid + Lanthio Pharma + AM-Pharma + De Novo Pharma + Antisoma) Chief Executive Officer (CEO) Apaxen S.A. Belgium
Wykeman, Nick (Allergy Therapeutics 201709 Finance Director) Chief Financial Officer (CFO) Allergy Therapeutics (Group) United Kingdom (GB)
Wülfing, Pia (PINK gegen Brustkrebs 202406 CEO + Co-Founder) Managing Director Sidekick Health (Group) Germany
Wüller, Conrad (ArtBio 202401 Director Strategy + Operations) Business Development Manager / Strategy Manager ArtBio (Group) United States (USA)
Wünsch, Josef R. (BASF 201109 Managing Director of BASF Venture Capital GmbH) Managing Director BASF (Group) Germany
Wüpper, Andreas (Fresenius 202202 Director of Investments at Fresenius Medical Care Ventures) Investment Manager Fresenius (Group) Germany
Würdinger, Reiner (JASCO 201204 Managing Director of JASCO Deutschland GmbH) Managing Director JASCO (Group) Germany
Würtenberger, Klaus (CorTec GmbH 201011 Managing Director) Managing Director CorTec GmbH Germany
Wyser-Pratte, Joelle (OCP Capital LLC 202010 Founder) Company Founder OCP Capital LLC United States (USA)
Wysocki, Vicki (Ohio State Univ 201509 Professor of Chemistry + Biochemistry + Head of Chemical Instrument Center) Professor Ohio State University United States (USA)
Wyss, André (Novartis –201803 President Novartis Operations LEFT 4/18) Board member, executive Novartis (Group) Switzerland
Wyss, Lorenz (Bell Food 201807 CEO) Chief Executive Officer (CEO) Bell Food (Group) Switzerland
Wyss, Roman (Enantios 202407 CTO + Co-Founder) Chief Technology/Technical Officer (CTO) Enantios AG Switzerland
Wüst, Bernhard (Agilent 201909 Global Marketing Manager for Sports Doping) Sales Manager / Marketing Manager Agilent (Group) United States (USA)
Wüstenberg, Arne (Celldeg GmbH 201609– Managing Director) Managing Director Celldeg GmbH Germany
Wüster, Rebekka (Boehringer 202404 Communication Lead BioXcellence) Public Relations Manager / Investor Relations Manager Boehringer Ingelheim (Group)
Wälder, Felix M. (Mainz (govt) 202401 Managing Director of biomindz) Managing Director Mainz (govt city) Germany
Wölfl, Stefan n. a. University of Heidelberg (Ruperto Carola) Germany
Xander, Karsten (Certania 202409 CEO + Co-Founder) Chief Executive Officer (CEO) Certania (Group) Germany
Xi, Hualin (Simon) (Rgenta Therapeutics 202004 CEO + CO-Founder) Chief Executive Officer (CEO) Rgenta Therapeutics Inc. United States (USA)
Xi, Zhang (Superlab Suisse 2019– CEO + Founder) Chief Executive Officer (CEO) Superlab Suisse (Group) Switzerland
Xia, Xiaokai (Sinopharm 202208 Managing Director of Shanghai GeneoDx) Managing Director Sinopharm (China National Pharmaceutical) (Group) China
Xinguang, Zhu (Chinese Academy of Sciences 201706 Prof at SIPPE) Professor China (govt) China
Xu, Caroline Man (ViGeneron 201911 CEO + Co-Founder) Chief Executive Officer (CEO) ViGeneron GmbH Germany
Xu, Yao-Chang (Abbisko Therapeutics 2023 CEO + Co-Founder) Chief Executive Officer (CEO) Abbisko Therapeutics Co. Ltd. China
Xue, James (Canbridge Life Sciences 201507 CEO) Chief Executive Officer (CEO) Canbridge Life Sciences Ltd. (CN)
Yadegardjam, Farsin (EVP Capital 201106 Executive Board Director) Board member, executive EVP Capital Management AG Germany
Yakneen, Sergei (Alphabet 202205– CTO at Isomorphic Labs before Sophia Genetics + Amazon + BPS) Chief Technology/Technical Officer (CTO) Alphabet (formerly Google) (Group) United Kingdom (GB)
Yamamoto, Kazuhiko (Synplogen 202212 CEO) Chief Executive Officer (CEO) Synplogen Co., Ltd. Japan
Yamanaka, Shinya (Univ Kyoto 201004– Director of CiRA + Nobel Laureate 2012) Professor University of Kyoto (Kyoto University) Japan
Yamane, Kenji (KKR 201506 President of Panasonic Healthcare + Panasonic Healthcare Holdings) President/Director/Head Business Group/Unit/Division PHC (Group) Japan
Yan, Zhiyu (Alan) (Sperogenix Therapeutics 202201 CEO + Co-Founder) Chief Executive Officer (CEO)
Yanchik, Joseph A., III (Aileron Therapeutics 201008 CEO) Chief Executive Officer (CEO) Aileron Therapeutics Inc. United States (USA)
Yang, Jerry (HCVC 202211 General Partner) General Partner (venture partner) HCVC (Hardware Club VC) France
Yang, Patrick (National Resilience 202106 Exec Vice Chairman + Board Member at Antheia formerly Roche/Genentech) Board member, executive National Resilience (Group) United States (USA)
Yang, Steve (WuXi PharmaTech 201604 EVP + COO of WuXi AppTec) Chief Operating Officer (COO) WuXi PharmaTech (Group) China
Yang, Xiaoming (Sinopharm 201704 Chairman of China National Biotech Group) President/Director/Head Business Group/Unit/Division Sinopharm (China National Pharmaceutical) (Group) China
Yang, Zhi (BVCF Management 202105 Chairman + Managing Partner + Founder) Managing Partner BVCF Management Ltd. (CN) (BioVeda China Fund) China
Yap, Greg (Menlo Ventures 202101 Partner formerly Desy + GE + Ventana + Cellective Dx + Affymetrix) Partner (venture partner) Menlo Ventures United States (USA)
Yap, Richard (Numares 201612– Managing Director of Numares Singapore before Avdisor + OrbusNeich) Managing Director Numares (Group) Singapore
Yaspo, Marie-Laure n. a. Source BioScience (Group) Germany
Yates, Robert (Merck (DE) 201109–201493 President of Merck Millipore before Roche Diagnostics LEFT 3/14) President/Director/Head Business Group/Unit/Division Merck (DE) (Group) United States (USA)
Yeager, Frank (Eckert & Ziegler 202305– promoted to Management Board Director for Isotope Products) Board member, executive Eckert & Ziegler (Group) Germany
Yee, Sidney (Singapore (govt) 201510 CEO of DxD Hub of A*STAR) Chief Executive Officer (CEO) Singapore (govt) Singapore
Yemm, Stephen (Steve) (Optibrium 202301– Chief Commercial Officer before Paradigm4 + Aigenpulse + BioData + Vialis) Chief Commercial Officer (CCO) Optibrium (Group) United Kingdom (GB)
Yerganian, Syrane (Strammer 201704 CFO) Chief Executive Officer (CEO) Strammer (Group) France
Yianni, John (CryoTherapeutics GmbH 201305 Managing Director) Managing Director CryoTherapeutics GmbH Germany
Yildiz, Marius (Murat) (Avergen Pharmaceuticals GmbH 201510– Managing Director) Managing Director Avergen Pharmaceuticals GmbH (APG) Germany
Ylisaukko-oja, Tero (MedEngine Oy 201901 CEO) Chief Executive Officer (CEO)
Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP) Chief Executive Officer (CEO) Palvella Therapeutics (Group) Germany
Yoo, Stephen (Anjarium Biosciences 202206– CEO before Third Harmonic Bio + Regenxbio + MedImmune + Abbott Labs) Chief Executive Officer (CEO) Anjarium Biosciences AG Switzerland
York, Gwill (Lighthouse Capital Partners 202110 Founding Managing Director) Managing Director Lighthouse Capital Partners (US) United States (USA)
Yoshitaka, Shinsuke (Denka 201508 President + CEO) Chief Executive Officer (CEO) Denka (Group) Japan
Young, Diane (Novartis Oncology 200601) n. a. Novartis (Group) Switzerland
Young, Jordan (Repare Therapeutics 202305 Director of SNIPRx platform) n. a.
Young, Joshua (Bruker 201301– VP Investor Relations before Merck KGA + Millipore LEFT BEFORE 7/16) Public Relations Manager / Investor Relations Manager Bruker (Group) United States (USA)
Yousaf, Shaf (Sigma-Aldrich 201412 VP Tech + BusDev before Life Technologies + Applied Biosystems + Sigma-Aldrich) President/Director/Head Business Group/Unit/Division Thermo Fisher (Group) United States (USA)
Yrjänheikki, Juha (Aurealis Pharma 201708 CEO) Chief Executive Officer (CEO) Aurealis Therapeutics AG Switzerland
Yu, Chen (TCG Crossover 202107 Managing Partner + Founder before Vivo Capital 201504 Managing Partner) Managing Partner (investment firm) Column Group LLC, The (TCG) United States (USA)
Yu, Frank (Ally Bridge Group 201702 CEO + CIO + Founder) Chief Executive Officer (CEO) Ally Bridge Group (ABG) China
Yu, Guo-Liang (Epitomics 201105 CEO) Chief Executive Officer (CEO) Danaher (Group) United States (USA)
Yu, Yuexin (Andera Partners 202201 Investment Director at Andera Life Sciences) Investment Manager New York Life (Group) France
Yule, Murray (iOmx Therapeutics 202202– CMO before MorphoSys) Chief Medical Officer (CMO) iOmx Therapeutics AG Germany
Yusibov, Vidadi (Fraunhofer USA 201009 Exec Director CMB + iBio 201009 CSO) Researcher (university / research institute) Fraunhofer (Group) United States (USA)
Yver, Antoine (AstraZeneca 201309 VP + Head of Oncology in Global Medicines Development Unit) President/Director/Head Business Group/Unit/Division AstraZeneca (Group) United Kingdom (GB)
Yzer, Cornelia (Berlin (govt) 201305 Senator of Economy, Technology, and Research) Minister Berlin (govt region) Germany
Yönel, Mutlu (Prosion 202308 Managing Director (CFO) + Co-Founder) Chief Financial Officer (CFO) Prosion GmbH (Prosion Therapeutics) Germany
next pagenext page 1 2 3 ... 93 94 95  next pagenext page



Advertisement

Picture Berlin Partner Life Sciences Report 2024-2025 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x300px

» top